Trastuzumab Modulates the Protein Cargo of Extracellular Vesicles Released by ERBB2(+) Breast Cancer Cells

Cancers overexpressing the ERBB2 oncogene are aggressive and associated with a poor prognosis. Trastuzumab is an ERBB2 specific recombinant antibody employed for the treatment of these diseases since it blocks ERBB2 signaling causing growth arrest and survival inhibition. While the effects of Trastu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Membranes (Basel)
Main Authors: Marconi, Silvia, Santamaria, Sara, Bartolucci, Martina, Stigliani, Sara, Aiello, Cinzia, Gagliani, Maria Cristina, Bellese, Grazia, Petretto, Andrea, Cortese, Katia, Castagnola, Patrizio
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8000509/
https://ncbi.nlm.nih.gov/pubmed/33809102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/membranes11030199
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki